“…In our study, besides whole LtP cells, Lainson & Shaw, 1987), and is not pathogenic for humans (Raymond et al, 2012). L. tarentolae has been widely used in pharmacological studies for (a) the screening of natural and synthetic products (Taylor et al, 2010), (b) the purification and characterization of proteins that are used for the screening of drugs with potential antileishmanial activity (Fritsche et al, 2007;Yakovich, Ragone, Alfonzo, Sackett, & Werbovetz, 2006), and (c) the amplification of genes involved in the resistance to certain antileishmanial drugs such as amphotericin B (Singh, Papadopoulou, & Ouellette, 2001) and sodium stibogluconate (Haimeur & Ouellette, 1998 (Monzote, Garcia, et al, 2014) and LtP (Geroldinger et al, 2017), the quantitative outcome of viability assays may strongly depend on the cell number to drug ratio, detection method and even on assay medium and premature activation of Asc in media. Our current studies explore this systematically.…”